Format

Send to

Choose Destination
See comment in PubMed Commons below
Regen Med. 2012 Nov;7(6 Suppl):26-31. doi: 10.2217/rme.12.64.

Stem cells and neurodegenerative diseases: where is it all going?

Author information

1
Cambridge Centre for Brain Repair, Department of Clinical Neuroscience, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 OPY, UK. rab46@cam.ac.uk

Abstract

Over the last few years there have been a number of major breakthroughs in the development of stem cells for diseases of the CNS. One of these has been in the ability to reprogram adult somatic cells to a more pluripotent state as well as directly to neurons and, by so doing, use patient-derived cells to study disease. In addition, the capacity to engineer embryonic stem cells to defined neuronal fates in the absence of proliferative contaminant cells is now feasible, which opens up the possibility of using these cells for cell transplantation. In this review, we will discuss how these developments have come about, particularly in the context of Parkinson's disease, and what this means for the future of this whole field over the next few years.

PMID:
23210808
DOI:
10.2217/rme.12.64
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center